Active Prosecution Continues for Controlled Substance Violations

March 17, 2021

Not So Fast: Biden Expected to Halt Expansion of Buprenorphine Prescribing

January 26, 2021

Confusion Persists with the 5% Rule

January 14, 2021

DEA Proposes Regulations for Partial Fills of C-IIs

December 3, 2020

DEA Creates Two-Option Framework for Reporting Suspicious Orders

October 30, 2020

ASPL Virtual Conference: Your Rx for Developments in Pharmacy Law

October 28, 2020

NTIS Ending Its DEA Registration Subscription Service

October 25, 2020

DEA Establishes Registration Category for EMS Agencies

October 4, 2020

DEA’s New/Old View on Due Diligence Requirements

September 30, 2020

DEA Proposes Significant Changes to Administrative Hearings

September 29, 2020